In a groundbreaking study conducted by Dr. Tapomoy Bhattacharjee’s lab at the National Centre for Biological Sciences (NCBS) in collaboration with Dr. Ramray Bhat’s lab at the Indian Institute of Science (IISc.), new insights have emerged regarding the regulation of ovarian cancer spheroids by calcium and pH levels. Published in the scientific journal Small, this […]
Category: microenvironment
Unveiling CD Bioparticles Cutting-Edge Tumor Organoid & CAF Co-culture Service for Revolutionary Cancer Research
CD Bioparticles is thrilled to introduce its groundbreaking Tumor Organoid & CAF Co-culture services, designed to propel cancer research to new heights. In a recent announcement, CD Bioparticles, a frontrunner in manufacturing and supplying top-tier drug delivery products and services, rolled out its innovative Tumor Organoid & CAF Co-culture services. These services are meticulously crafted […]
STX-001 mRNA Therapeutics Shows Promise in Treating Advanced Solid Tumors
In a groundbreaking development, Strand Therapeutics has revealed the initial Phase 1 data for STX-001 in patients with advanced solid tumors. This mRNA therapeutic aims to address the urgent need for new treatment options in patients who are resistant to immune checkpoint inhibitors. By delivering localized IL-12 expression to activate the tumor microenvironment and stimulate […]
